Personalis, Inc. (PSNL)
16.79
+0.06
(+0.36%)
USD |
NASDAQ |
Sep 03, 10:42
Personalis Research and Development Expense (TTM) : 56.12M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.12M |
| March 31, 2026 | 52.16M |
| December 31, 2025 | 50.26M |
| September 30, 2025 | 48.69M |
| June 30, 2025 | 48.20M |
| March 31, 2025 | 48.77M |
| December 31, 2024 | 48.90M |
| September 30, 2024 | 51.02M |
| June 30, 2024 | 56.08M |
| March 31, 2024 | 60.97M |
| December 31, 2023 | 64.78M |
| September 30, 2023 | 67.73M |
| June 30, 2023 | 65.95M |
| March 31, 2023 | 64.39M |
| December 31, 2022 | 64.91M |
| September 30, 2022 | 62.86M |
| Date | Value |
|---|---|
| June 30, 2022 | 61.52M |
| March 31, 2022 | 56.91M |
| December 31, 2021 | 49.31M |
| September 30, 2021 | 43.32M |
| June 30, 2021 | 36.90M |
| March 31, 2021 | 31.67M |
| December 31, 2020 | 28.57M |
| September 30, 2020 | 27.42M |
| June 30, 2020 | 25.53M |
| March 31, 2020 | 23.56M |
| December 31, 2019 | 22.42M |
| September 30, 2019 | 19.33M |
| June 30, 2019 | 17.60M |
| March 31, 2019 | 16.60M |
| December 31, 2018 | 14.30M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tempus AI, Inc. | 364.39M |
| 10X Genomics, Inc. | 226.80M |
| Alamar Biosciences, Inc. (California) | 44.03M |
| Adaptive Biotechnologies Corp. | 80.01M |
| Champions Oncology, Inc. | 9.084M |